CNR Neuroscience Institute, Milan, Milano, Italy.
University of Perugia, Department of Experimental Medicine, Perugia, Italy.
Mol Psychiatry. 2021 Jun;26(6):1928-1944. doi: 10.1038/s41380-020-00979-x. Epub 2021 Jan 5.
Human mutations and haploinsufficiency of the SHANK family genes are associated with autism spectrum disorders (ASD) and intellectual disability (ID). Complex phenotypes have been also described in all mouse models of Shank mutations and deletions, consistent with the heterogeneity of the human phenotypes. However, the specific role of Shank proteins in synapse and neuronal functions remain to be elucidated. Here, we generated a new mouse model to investigate how simultaneously deletion of Shank1 and Shank3 affects brain development and behavior in mice. Shank1-Shank3 DKO mice showed a low survival rate, a developmental strong reduction in the activation of intracellular signaling pathways involving Akt, S6, ERK1/2, and eEF2 during development and a severe behavioral impairments. Our study suggests that Shank1 and Shank3 proteins are essential to developmentally regulate the activation of Akt and correlated intracellular pathways crucial for mammalian postnatal brain development and synaptic plasticity. Therefore, Akt function might represent a new therapeutic target for enhancing cognitive abilities of syndromic ASD patients.
人类突变和 SHANK 家族基因的杂合缺失与自闭症谱系障碍 (ASD) 和智力障碍 (ID) 有关。Shank 突变和缺失的所有小鼠模型均表现出复杂的表型,与人类表型的异质性一致。然而,Shank 蛋白在突触和神经元功能中的具体作用仍有待阐明。在这里,我们构建了一个新的小鼠模型来研究 Shank1 和 Shank3 的同时缺失如何影响小鼠的大脑发育和行为。Shank1-Shank3 DKO 小鼠的存活率较低,在发育过程中,涉及 Akt、S6、ERK1/2 和 eEF2 的细胞内信号通路的激活受到强烈抑制,并且表现出严重的行为障碍。我们的研究表明,Shank1 和 Shank3 蛋白对于发育过程中 Akt 的激活以及对哺乳动物出生后大脑发育和突触可塑性至关重要的相关细胞内途径的调节至关重要。因此,Akt 功能可能代表增强综合征性 ASD 患者认知能力的新治疗靶点。